Quality Metrics to foster Continual Quality Improvement
Im Auftrag der European Compliance Academy

Quality Metrics to foster Continual Quality Improvement Im Auftrag der European Compliance Academy

Heidelberg, Germany

Seminar Nr. 15660

Unser Seminarservice

Kosten

HABEN SIE INTERESSE AN DEM SEMINAR?

Bitte kontaktieren Sie uns und wir informieren Sie:

Anfrage stellen

Rückfragen unter:
Tel.: 06221 / 84 44 0 E-Mail: info@concept-heidelberg.de

Sprecher

Arnoud Herremans, Lean Kaizen Consultant,The Netherlands

Henny Koch, Qimp Management Systems, The Netherlands

Dorthe Christina Kroun, Bavarian Nordic A/S, Denmark

Dr Daniel Marquardt, Boehringer Ingelheim, Germany

Dr Ann McGee, McGee Pharma International,Ireland

Zielsetzung

This 2-day Master Class brings together well-experienced experts to discuss the latest expectations and requirements for Quality Metrics and KPIs and how they are linked to Continual Quality Improvement (CQI) and Business Continuity. This will support you turning your company’s quality excellence goals into reality.

Hintergrund

To remain ‘regulatory compliant’ and to ensure the continuity of product supply in a cost-effective way, systems and processes must be evaluated and the respective processes simplified and controlled. Important tools in this context are accurate Quality Metrics, the right Key Performance Indicators (KPIs) and Continual Quality Improvement.

Quality Metrics in itself are not new, though. They have already been used in pharmaceutical industry for years – even though mainly internally to measure operational performance. But quality can be measured on different levels and for many processes. Done in the right way, Quality Metrics can enable companies to reach a high quality performance. They will benefit from a continuous improvement in both operational performance and GMP compliance. And both are important for the continuity of business and product supply.

Now, the U.S. FDA has set up an initiative to use Quality Metrics for risk based inspections and published a draft Guidance for Industry in July 2015. In Europe agencies also use Quality Metrics. They are aiming to help regulators to separate manufacturing sites with poor standards from those continuously working on quality improvement.
In the end Quality Metrics will enable companies and regulators to benefit from a continuous investment in GMP to guarantee a high quality performance and the continuity of quality product supply.

Zielgruppe

Managers and Executives from pharmaceutical Quality Assurance and Quality Management but also Business Executives and Production Managers and those involved managing the continuity of product supply.

Programm

Quality Metrics and beyond

  • FDA’s Quality Metrics Initiative
  • Expectations in the EU
  • Quality Culture as the basis for quality improvements
  • How to involve the management in Quality Metrics
  • Set up of a practical review system
  • Follow up actions on management reviews
Integration of Quality Metrics Systems and KPIs in Continuous Improvement and Business Continuity
  • Understanding critical processes & where quality risks lie/ process mapping
  • Defining the right KPIs
  • Meaningful metrics (and the pitfalls)
  • The role of Quality Impact Assessment & effectiveness checks
  • The link to Opportunities for Improvement (OFIs), Continuous Quality Improvements (CQIs) and Business Continuity
Techniques to evaluate Quality Performance
  • Process Analysis
  • Root Cause Analysis
  • Cause-and-Effect Diagrams
  • Risk Assessment
  • Quality Cockpit
  • KPIs
  • Tracking & Trending
Assignment of Metrics and Correlation with Process Controls
  • The importance of proper use and relevance of lagging and leading KPIs in correlation with process controls.
  • The set up and implementation of a risk based data evaluation methods for continual improvement and the Management Review
Psychological Aspects of Continuous Improvement
  • What do the numbers tell us?
  • Business culture
  • Empowerment of people
Change Management as the Key
  • How to shift individuals, teams, and organisations from a current state to a desired future state
  • How to organise processes to empower employees to accept and embrace changes in their current business environment
  • 8 Steps of Change (Kotter)
Wrap-up: What the Future will bring
  • True understanding of the quality risks specific to our businesses
  • A shift to pro-active QRM from reactive risk assessment
  • Integration of QRM and change management
  • Moving away from the functional silo mentality
  • Process and QMS improvement in the interest of patient care
  • Meaningful performance evaluation criteria and metrics
Case Study: Quality Metrics as a Key Driver for CQI
  • Why did we implement Metrics?
  • How did we do it?
  • What was the outcome?
  • Lessons learned
  • How to apply Quality Metrics as a Key Driver for CQI

Parallel sessions (2 out of 3)


1. Managing Data: The Bridge from Quality Metrics to CQI
Defining the right KPIs and Meaningful metrics (work on examples)
What to learn from the data

2. The new FDA Guideline on Quality Metrics – what is it all about?
Overview about the current status
Key areas and data to be submitted
How industry can prepare
The link to ICH Q12: Quality Metrics as part of Product Lifecycle Management

3. Analysis Tools for assessing and optimising Process Flows
How to choose and use the correct tools

You will be able to attend 2 of these sessions. Please choose the ones you like to attend when you register for the course.

Zurück

GMP Seminare nach Thema

Cookies helfen uns bei der Bereitstellung unserer Dienste. Durch die Nutzung unserer Dienste erklären Sie sich damit einverstanden, dass wir Cookies setzen. Weitere Informationen

OK